Research of Usher Syndrome has been linked to Retinitis Pigmentosa, Complete Hearing Loss, Sensorineural Hearing Loss (disorder), Blind Vision, Retinal Degeneration. The study of Usher Syndrome has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Usher Syndrome include Localization, Pathogenesis, Transport, Translation, Cell Death. These pathways complement our catalog of research reagents for the study of Usher Syndrome including antibodies and ELISA kits against MYO7A, USH1C, CLRN1, USH2A, PCDH15.
Usher Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Usher Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 226 products for the study of Usher Syndrome that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Usher Syndrome is also known as usher syndrome, dystrophia retinae pigmentosa-dysostosis syndrome, retinitis pigmentosa-deafness-ataxia syndrome, retinitis pigmentosa 21, formerly, retinitis pigmentosa 8, formerly, usher's syndrome, rp21, formerly, rp8, formerly, dystrophy.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.